Finance

Lists
NWBO:OTCMKTS
Northwest Biotherapeutics Inc
$0.17
-2.56%
(-0.0046) 1D
Aug 20, 1:19:02 PM GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for NWBO...
Open
$0.18
High
$0.18
Low
$0.17
Mkt. cap
291.06M
Avg. vol.
3.19M
Volume
1.42M
52-wk high
$0.37
52-wk low
$0.14
EPS
-$0.03
Beta
-0.60
Shares outstanding
1.71B
No. of employees
105
Open
$0.18
High
$0.18
Low
$0.17
Mkt. cap
291.06M
Avg. vol.
3.19M
Volume
1.42M
52-wk high
$0.37
52-wk low
$0.14
EPS
-$0.03
Beta
-0.60
Shares outstanding
1.71B
No. of employees
105
Profile
Northwest Biotherapeutics, Inc. is a development-stage American pharmaceutical company headquartered in Maryland that focuses on developing immunotherapies against different types of cancer. It was founded in 1996 by Alton L. Boynton. Wikipedia
About Northwest Biotherapeutics Inc
CEO-
Employees105
FoundedJan 1, 1998
Headquarters-
SectorBiotechnology
Websitenwbio.com
Previous reportsAll values in USD
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in USD
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Revenue
200.00K
672.00K
494.00K
807.00K
Cost of goods sold
7.45M
5.55M
4.86M
5.70M
Cost of revenue
7.45M
5.55M
4.86M
5.70M
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
7.07M
8.62M
6.54M
6.71M
Operating expense
7.07M
8.62M
6.54M
6.71M
Total operating expenses
14.52M
14.18M
11.39M
12.41M
Operating income
-14.32M
-13.50M
-10.90M
-11.60M
Other non operating income
-3.45M
1.14M
9.53M
64.00K
EBT including unusual items
-26.83M
851.00K
-3.07M
-9.22M
EBT excluding unusual items
-21.20M
-14.82M
-5.06M
-13.47M
Income tax expense
-
-537.00K
-
-
Effective tax rate
-
-63.10%
-
-
Other operating expenses
-
-
-
-
Net income
-26.83M
1.39M
-3.07M
-9.22M
Net profit margin
-13,414.50%
206.55%
-621.25%
-1,142.63%
Earnings per share
-
-
-
-
Interest and investment income
-
-
-
-
Interest expense
-2.62M
-2.65M
-2.35M
-1.81M
Net interest expenses
-2.62M
-2.65M
-2.35M
-1.81M
Depreciation and amortization charges
-
-
-
-
EBITDA
-13.87M
-12.78M
-10.13M
-10.83M
Gain or loss from assets sale
-
-
-
-
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer

Research

What's on your mind?
What's going on with the markets today?
Explore what’s possible
Create a portfolio
Create a task
Deep Search
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
Google apps